Pharmacokinetics of Dabrafenib in Subjects With Hepatic Impairment
Clinical trial NCT02873650 · TERMINATED
Trial details
- NCT number
- NCT02873650
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-20
- Primary completion
- 2018-10-12
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.